Olivia Correa

Medicare PDPs to Have Annual Out-of-Pocket Cap Starting in 2025

Starting in January 2025, significant changes will be coming to Medicare prescription drug plans (PDPs) that aim to make prescription medications more affordable for millions of Americans. As part of the Inflation Reduction Act, the federal government is implementing an annual out-of-pocket cap of $2,000 on covered prescription medications. This move is designed to ease […]

Medicare PDPs to Have Annual Out-of-Pocket Cap Starting in 2025 Read More »

Public Health Risk

CDC Warns of Potential Public Health Risk from Online Pharmacies and Counterfeit Medications

The Centers for Disease Control and Prevention (CDC) has issued a warning about the public health risk associated with online pharmacies. The warning specifically highlights the dangers posed by pharmacies that sell counterfeit or substandard medications. As more people turn to the internet to purchase prescriptions, the risk of unknowingly obtaining harmful medications increases. Many

CDC Warns of Potential Public Health Risk from Online Pharmacies and Counterfeit Medications Read More »

nurse practitioner

Honoring Excellence: Celebrating National Nurse Practitioner Week

At Atlantic Biologicals, we are proud to join the healthcare community in recognizing National Nurse Practitioner Week (November 12-18). This is a time to honor the vital role that nurse practitioners (NPs) play in our healthcare system. As front-line providers, NPs deliver high-quality care to patients across a range of settings, improving access and outcomes

Honoring Excellence: Celebrating National Nurse Practitioner Week Read More »

inflating insulin prices

FTC Sues Prescription Middlemen for Artificially Inflating Insulin Prices: What It Means for the Healthcare Industry

The high cost of insulin has been a significant concern in the United States for years. Millions of people depend on this life-saving medication, yet its price continues to rise, putting a heavy financial burden on patients with diabetes. Recently, the Federal Trade Commission (FTC) took action, filing a lawsuit against prescription middlemen, accusing them

FTC Sues Prescription Middlemen for Artificially Inflating Insulin Prices: What It Means for the Healthcare Industry Read More »

Medication Spending

Rise in Medication Spending Not Reflected in Hospital Pharmacies

Recent data from a new ASHP (American Society of Health-System Pharmacists) report reveals an intriguing trend in prescription medication spending across the United States. While the overall national expenditure experienced a significant surge, increasing by 13.5% from 2022 to 2023 and totaling a staggering $722.5 billion, this growth was not mirrored in hospital pharmacy spending.

Rise in Medication Spending Not Reflected in Hospital Pharmacies Read More »

ovarian and prostate cancer

September: A Time to Raise Awareness for Ovarian and Prostate Cancer

This September, hospital pharmacies are encouraged to play an active role in raising awareness about ovarian and prostate cancer. By educating patients on the symptoms, risk factors, and treatment management, you can improve early detection and patient outcomes. Ovarian Cancer Awareness Key Symptoms for Pharmacists to Watch For: Patients may visit hospital pharmacies with prescriptions

September: A Time to Raise Awareness for Ovarian and Prostate Cancer Read More »

Bipartisan Bill

Lawmakers Introduce Bipartisan Bill to Crack Down on Medication Middlemen

To address rising concerns over prescription medication costs, bipartisan lawmakers have introduced a bill to regulate pharmacy benefit managers (PBMs). This legislation aims to bring transparency and accountability to an industry criticized for driving up medication costs in the United States. The Role of Pharmacy Benefit Managers Pharmacy benefit managers act as intermediaries between insurance

Lawmakers Introduce Bipartisan Bill to Crack Down on Medication Middlemen Read More »

Pfizer's Gene Therapy

Breakthrough in Hemophilia Treatment: Pfizer’s Gene Therapy Shows Promising Results

Pfizer’s recent advancements in gene therapy have shown significant promise in reducing bleeding episodes for hemophilia patients, marking a potential breakthrough in the treatment of this chronic condition. Hemophilia, a genetic disorder that impairs the body’s ability to make blood clots, can lead to spontaneous and prolonged bleeding. Current treatments often involve regular infusions of

Breakthrough in Hemophilia Treatment: Pfizer’s Gene Therapy Shows Promising Results Read More »

Preventive Services Task Force

U.S. Court of Appeals Partially Affirms Ruling on Preventive Services Task Force

In a significant legal development, the 5th Circuit Court partially affirmed a ruling that deemed the Preventive Services Task Force unconstitutional. This task force is responsible for determining the coverage of certain preventive services under the Affordable Care Act (ACA). Additionally, the appellate court upheld the grant of injunctive relief for the plaintiffs in the

U.S. Court of Appeals Partially Affirms Ruling on Preventive Services Task Force Read More »